TTEC unveils new healthcare digital sales model

Published 27/03/2025, 21:06
TTEC unveils new healthcare digital sales model

AUSTIN, Texas - TTEC Holdings, Inc. (NASDAQ:TTEC), a prominent provider of customer experience technologies and services with annual revenue of $2.2 billion, has introduced a new digital sales model tailored for the healthcare industry. According to InvestingPro analysis, while the company currently faces challenges with a significant debt burden, analysts expect net income growth in the coming year. The company announced the launch of its blended healthcare digital sales model designed to offer cost-effective and scalable solutions that prioritize personalized customer interactions for healthcare organizations.

The model is built on a shared technology platform, which allows healthcare entities to adopt a unified digital sales approach without compromising their brand identity or data security. TTEC’s model integrates its award-winning technology with a team of skilled associates to streamline digital sales processes and provide brand-specific customer experiences. With a current ratio of 1.84, the company maintains strong liquidity to support its technological initiatives, though InvestingPro data indicates the company is currently experiencing accelerated cash burn.

TTEC claims that its new model can lead to significant cost savings for healthcare organizations, potentially up to 30%, by optimizing staffing and technology resources. The model employs a cloud-based contact center as a service (CCaaS) platform, which combines telephony, customer relationship management (CRM), and functionalities such as "quote, shop, and apply" to enhance operational efficiency.

Moreover, TTEC’s approach is designed to increase sales conversions through AI-driven insights and strategies. The company also emphasizes the importance of personalized support from licensed associates to improve member satisfaction and reflect the healthcare brand’s values.

John Abou, President of TTEC Engage, stated, "Our blended healthcare digital sales model redefines how healthcare organizations approach member acquisition and engagement. By combining the power of technology with personalized service, we help our clients reduce costs, increase sales, and enhance member experiences – all while maintaining rigorous data security standards."

In line with the emphasis on data protection, TTEC ensures that its model adheres to HIPAA-compliant security protocols, with data encryption at-rest and in-transit using AES 256-bit encryption to maintain client information privacy.

With over two decades of experience in supporting healthcare organizations, TTEC continues to focus on delivering customer-centric digital sales solutions that yield tangible results. While the company’s stock has seen significant pressure over the past year, trading near its 52-week low, analysts maintain a consensus hold rating with three analysts recently revising earnings estimates upward. For deeper insights into TTEC’s financial health and growth prospects, investors can access the comprehensive Pro Research Report available on InvestingPro, which includes detailed analysis of the company’s performance metrics and future outlook.

The information provided in this article is based on a press release statement from TTEC Holdings, Inc.

In other recent news, TTEC Holdings Inc. reported a decline in its fourth-quarter 2024 earnings, missing analyst forecasts on both earnings per share (EPS) and revenue. The company posted an EPS of $0.19, falling short of the expected $0.21, and reported revenue of $567.4 million, which was below the anticipated $575.2 million. For the full year 2024, TTEC’s revenue decreased by 10.4% compared to 2023, amounting to $2.21 billion. The company also noted a year-over-year decline in revenue for its Digital and Engage segments, primarily due to reduced healthcare volumes and the loss of a significant financial services client.

Looking ahead, TTEC has provided guidance for 2025, projecting revenue between $2,014 and $2,064 million. The company anticipates a non-GAAP adjusted EBITDA margin of 10.7% to 11.4% and an adjusted EPS forecast ranging from $0.95 to $1.20. Canaccord Genuity recently adjusted its outlook on TTEC, lowering the stock target to $3.50 from $4.50 while maintaining a Hold rating. This revision reflects the latest financial results and future projections provided by TTEC. Despite challenges, TTEC continues to focus on AI integration across its services and expects revenue growth in the latter half of 2025.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.